Charles River Laboratories International, Inc. (RV6)
FSX
Closed
Sep 25, 2026
Day's Range
258.1052 wk Range
124.25Overview - RV6 - Charles River Laboratories International, Inc.
Key Statistics
Valuation
Enterprise Value
12.14B
P/E (Trailing)
‪564.99‬
P/E (Forward)
‪20.31‬
PEG Ratio
‪-5.49‬
Price / Sales (TTM)
‪2.80‬
Price / Book
‪4.59‬
EV / EBITDA
‪16.62‬
Profitability
Gross Margin
‪36.18%‬
Profit Margin
‪-5.96%‬
Operating Margin
‪15.11%‬
Return on Assets
‪4.10%‬
Return on Equity
‪-7.51%‬
Ownership
Shares Outstanding
47.72M
Float
47.22M
Held by Insiders
‪0.47%‬
Held by Institutions
‪123.08%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪223.48‬
200-Day Avg
‪173.76‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RV6 - Charles River Laboratories International, Inc.
Peers - RV6 - Charles River Laboratories International, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
- RV6FSXCharles River Laboratories International, Inc.11.22BMarket Cap+44.73%52-week change565.00P/E (Trailing)‪-5.96%‬Profit Margin
- TN8FSXThermo Fisher Scientific Inc.218.52BMarket Cap+33.54%52-week change36.19P/E (Trailing)‪15.03%‬Profit Margin
- TN80FSXThermo Fisher Scientific CDR (CAD Hedged)185.99BMarket Cap+15.94%52-week change31.86P/E (Trailing)‪15.03%‬Profit Margin
- DAPFSXDanaher Corp.132.16BMarket Cap+3.30%52-week change37.98P/E (Trailing)‪15.94%‬Profit Margin
- SONAFSXSony Group Corp. Sponsored ADR116.90BMarket Cap-24.00%52-week change19.42P/E (Trailing)‪-1.74%‬Profit Margin
- WX8FSXWuXi AppTec Co., Ltd.71.50BMarket Cap+44.40%52-week change3.23P/E (Trailing)‪42.25%‬Profit Margin
- 45EFSXNatera, Inc.52.13BMarket Cap+76.22%52-week change-237.96P/E (Trailing)‪-7.10%‬Profit Margin
Profile Summary - RV6 - Charles River Laboratories International, Inc.
About
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages. Charles River Laboratories provides research models, discovery services, non-clinical safety assessment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
